logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

In the past week, IBIT saw the highest fund inflows, ranking first on BlackRock's ETF list, with ETHA coming in fifth.
Trump Seeks to Impose Tariffs of at Least 15-20% on All EU Goods

You may also like

Share
copy

Gainers

Latest Crypto News

10:45

Key Transaction Data: US 10-Year Treasury Yield Rises to 4.086%

10:45

Mainstream Perp DEX Overview: Hyperliquid Surpasses $10 Billion in Trading Volume Again, Platform Volumes Rebound Collectively

10:45

The European Stablecoin Alliance Appoints Former Coinbase Executive as Chief Executive Officer

10:15

Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, Deposited 23,000 ETH to CEX in the Past Week

10:15

The Central Bank of Russia has confirmed that it may relax cryptocurrency regulation rules.

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]